Simran Farms (519566)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹136.5 |
| Market Cap | ₹52.23 Cr |
| P/E Ratio | 0 |
| ROCE | 12.26% |
| ROE | -2.79% |
| Dividend Yield | 0% |
| Profit Growth | 707.14% |
| Debt/Equity | — |
| Sales Growth | -5.1% |
| 52-Week Range | ₹131.6 — ₹198 |
| Sector | Food Products |
| Book Value | ₹102.7 |
Strengths
- Positive ROCE of 12.26% indicates operating capital is earning a return
- Piotroski F-Score of 6/9 suggests some balance-sheet and profitability improvement
- Book value of ₹102.70 with P/B of 1.33; price is near the 52-week low of ₹131.60
- Quarterly sales of ₹233 Cr dwarf the ₹52 Cr market cap, giving a very low price-to-sales multiple
Concerns
- Net profit margin is extremely thin: ₹1 Cr profit on ₹233 Cr sales (~0.4%)
- ROE is negative at -2.79%, so shareholder equity is not earning a return
- Sales are declining at -5.10%, and trailing P/E is 0.00, making earnings-based valuation meaningless
- No dividend; debt/equity, promoter holding, and fair-score data are unavailable
AI Analysis
Simran Farms is the kind of small, unproven operation that demands extra caution. A poultry and meat processor has no inherent moat; it is a commodity business competing on price and cost efficiency. The numbers reinforce my scepticism. Latest quarter sales of ₹233 Cr generated only ₹1 Cr net profit—a 0.4% margin. That is not a robust business; it is a razor-thin float. ROE is negative at -2.79%, so shareholder equity is earning nothing. Book value is ₹102.70, and the stock trades at ₹136.50, a 33% premium to book. For a business with negative return on equity, I do not want to pay a premium. ROCE is positive at 12.26%, suggesting operations cover capital costs before interest and taxes, but the shareholder bottom line remains weak. Sales declined 5.10%, showing no growth engine. The 707% profit growth looks exciting but comes off a base near zero—the latest quarterly net profit is just ₹1 Cr. Mr. Market has put the stock near its 52-week low, likely pricing in poor economics. The Piotroski score of 6/9 signals some improvement in financial health, but I refuse to pay for hope. There is no dividend, and missing debt and promoter holding data makes management quality and balance-sheet risk impossible to judge. In Graham's language, this is not a defensive stock. At best, it is a small speculative turnaround, and only if earnings stabilise and margins genuinely expand. The margin of safety is absent.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer